Adding low-dose ipi to pembro seems safer, still effective for advanced melanomaJune 12, 2020Melanoma
Biologics may carry melanoma risk for patients with immune-mediated inflammatory diseasesJune 8, 2020MelanomaPsoriasisPsoriatic Arthritis
COVID-19 death rate was twice as high in cancer patients in NYC studyMay 5, 2020COVID-19 UpdatesMelanomaNonmelanoma Skin CancerPediatrics
Home-based chemo skyrockets at one U.S. centerApril 10, 2020COVID-19 UpdatesMelanomaNonmelanoma Skin Cancer
NCCN panel: Defer nonurgent skin cancer care during pandemicApril 7, 2020COVID-19 UpdatesMelanomaNonmelanoma Skin Cancer
‘Brutal’ plan to restrict palliative radiation during pandemicApril 6, 2020COVID-19 UpdatesMelanomaNonmelanoma Skin CancerPediatrics
Advice from the front lines: How cancer centers can cope with COVID-19April 2, 2020COVID-19 UpdatesMelanomaNonmelanoma Skin CancerPediatrics
No staff COVID-19 diagnoses after plan at Chinese cancer centerApril 2, 2020COVID-19 UpdatesMelanomaNonmelanoma Skin CancerPediatrics
Maintaining cancer care in the face of COVID-19April 1, 2020COVID-19 UpdatesMelanomaNonmelanoma Skin CancerPediatricsInfectious DiseasesBusiness of Medicine
Perspective from the heartland: Cancer care and research during a public health crisisMarch 26, 2020COVID-19 UpdatesMelanomaNonmelanoma Skin Cancer
Cancer care and COVID-19 in Seattle, the first U.S. epicenterMarch 23, 2020COVID-19 UpdatesMelanomaNonmelanoma Skin Cancer
